KLK3 and prostate carcinoma: In addition, the differentiation between aggressive and non-aggressive prostate cancer based on PSA α2–3-sialylation showed high sensitivity, specificity and accuracy, which indicated that α2–3-sialic acid content on PSA can improve prostate cancer diagnosis and clinical decision making [90].